Avinger Inc (AVGR)
3.84
+0.10
(+2.67%)
USD |
NASDAQ |
May 01, 16:00
3.84
0.00 (0.00%)
After-Hours: 20:00
Avinger Cash from Financing (Quarterly): -0.061M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.061M |
| September 30, 2023 | 5.136M |
| June 30, 2023 | 0.058M |
| March 31, 2023 | -0.021M |
| December 31, 2022 | -0.002M |
| September 30, 2022 | 4.799M |
| June 30, 2022 | 0.399M |
| March 31, 2022 | 6.721M |
| December 31, 2021 | -0.034M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 13.08M |
| December 31, 2020 | -0.002M |
| September 30, 2020 | 12.01M |
| June 30, 2020 | 10.11M |
| March 31, 2020 | 3.889M |
| December 31, 2019 | 0.009M |
| September 30, 2019 | 3.829M |
| June 30, 2019 | 1.671M |
| March 31, 2019 | 6.358M |
| Date | Value |
|---|---|
| December 31, 2018 | 10.05M |
| September 30, 2018 | 3.213M |
| June 30, 2018 | 0.366M |
| March 31, 2018 | 15.86M |
| December 31, 2017 | 0.396M |
| September 30, 2017 | 3.19M |
| June 30, 2017 | -0.006M |
| March 31, 2017 | 0.23M |
| December 31, 2016 | 3.716M |
| September 30, 2016 | 32.06M |
| June 30, 2016 | 10.98M |
| March 31, 2016 | 0.317M |
| December 31, 2015 | 0.086M |
| September 30, 2015 | 6.643M |
| June 30, 2015 | 0.002M |
| March 31, 2015 | 65.22M |
| December 31, 2014 | 6.236M |
| September 30, 2014 | 11.58M |
| June 30, 2014 | 4.197M |
| March 31, 2014 | 0.003M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.061M
Minimum
Dec 2023
13.08M
Maximum
Mar 2021
3.242M
Average
0.399M
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 0.352M |
| Retractable Technologies Inc | -0.1364M |
| Xtant Medical Holdings Inc | 0.325M |
| Asensus Surgical Inc | 0.172M |
| Catheter Precision Inc | -0.107M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.389M |
| Free Cash Flow | -14.44M |
| Free Cash Flow Per Share (Quarterly) | -2.648 |
| Free Cash Flow to Equity (Quarterly) | -3.888M |
| Free Cash Flow Yield | -479.8% |